- 10 minutes
- Expertise article | APVS 2017
- N Duangwhae, P Phoomiwattananon, C Maala
Country: Thailand
Source: 2017 The 8th Asian Pig Veterinary Society Congress
The results of this study demonstrated poor efficacy performance using Type I vaccine in the farm positive for PRRSV type II compared to a VR2332 based vaccine.
Porcine Reproductive and Respiratory Syndrome (PRRS) is the most economic impact of swine disease for pork producers. PRRS vaccines have been considered to be the most useful tool to control this fatal disease. Considering type of vaccine strain aligned with farm’s epidemiology is the universal recommendation over the world.
The objective of this study was to observe the nursery performance comparing the 2 different type PRRS vaccines, type I and type II in the same farms.
Key points:
- A retrospective study in a 2400 sow, single site production system with 3 separated units and PRRSV2-positive.
- Nursery performance comparing 2 different type PRRS vaccine, type 1 and type 2, was assessed.
- The PRRSV2-based vaccine (Ingelvac PRRS MLV) improved the farm performance and provided better efficacy than the PRRSV1-based vaccine.